Features associated with MASLD post-LT were pre-LT hypertension, post-LT diabetes, hypertriglyceridemia, MS, BMI, central obesity, fasting glucose, glycohemoglobin, triglycerides and ALT levels. The gene discussed is GPT; the disease is myeloid sarcoma.